Verbatim response from Claude
This is a fast-moving area, so I want to be straightforward with you:
Important Context First
The FDA declared the semaglutide shortage over in early 2025, which means compounded semaglutide is largely no longer legally permitted from 503A pharmacies. The situation is still evolving with ongoing legal challenges.
Services Still Navigating This Space
Hims & Hers - Has been fighting this legally and offered compounded options longest, but faced FDA pressure. Check their current status directly.
Ro - Has adjusted offerings; may still offer some compounded versions depending on legal developments.
LifeMD - Continues adapting its GLP-1 offerings as regulations shift.
Henry - Similar situation, adjusting in real time.
Honest Caveats
- Status changes weekly based on court rulings and FDA enforcement
- Some smaller telehealth services may still offer compounded versions in legally gray areas - I'd be cautious
- 503B compounders may still have some pathways for specific patient needs
My Recommendation
- Check each service's current website directly - this changes rapidly
- Ask specifically what pharmacy compounds their product
- Consider branded options (Ozempic, Wegovy, Zepbound) if coverage has improved for you
Would you like help thinking through the branded medication access options instead?